Comment on "Association between nirmatrelvir plus ritonavir and the outcomes of non-hospitalized obese patients with COVID-19"

Int J Antimicrob Agents. 2024 Feb;63(2):107063. doi: 10.1016/j.ijantimicag.2023.107063. Epub 2023 Dec 14.
No abstract available

Publication types

  • Letter

MeSH terms

  • COVID-19 Drug Treatment
  • COVID-19*
  • Humans
  • Lactams*
  • Leucine*
  • Nitriles*
  • Proline*
  • Ritonavir / therapeutic use

Substances

  • nirmatrelvir
  • Ritonavir
  • Lactams
  • Leucine
  • Nitriles
  • Proline